SPCC622.15c Antibody

What is SPCC622.15c and why is it significant for research?

SPCC622.15c is a gene identification code for a protein found in Schizosaccharomyces pombe (fission yeast), likely related to the Sup11p protein that plays critical roles in cell wall organization and remodeling processes. Antibodies against this target are valuable for investigating cell wall synthesis mechanisms and fungal cell biology. Cell wall research in S. pombe provides insights into fundamental eukaryotic processes and potential antifungal targets, as significant cell wall remodeling occurs during protein depletion studies .

How should researchers validate antibody specificity for SPCC622.15c?

Antibody validation requires a multi-step approach similar to established protocols for other research antibodies:

• Western blotting: Confirm single band of expected molecular weight

• Immunoprecipitation: Verify pull-down of target protein

• Knockout/knockdown controls: Use SPCC622.15c deletion mutants as negative controls

• Cross-reactivity testing: Test against related proteins, particularly other glucan synthases

• Epitope mapping: Identify specific binding regions to confirm target recognition

Validation should include appropriate positive and negative controls and follow protocols similar to those established for other research antibodies such as PARP-1 antibodies, which require verification across multiple applications including western blotting (1/1000-1/5000 dilution range) .

What cloning strategies are most effective for generating antibodies against S. pombe proteins like SPCC622.15c?

For generating effective antibodies against S. pombe proteins:

• Immunogen selection: Target unique, accessible epitopes (typically 15-20 amino acids)

• Expression system optimization: Use bacterial or mammalian expression systems with affinity tags

• Fusion partner selection: For monoclonal antibody development, select appropriate fusion partners (e.g., NS0 or NS-1 myeloma cell lines as used for PARP-1 and CD62P antibodies)

• Screening methodology: Implement robust screening against recombinant protein and native protein extracts

• Hybridoma stabilization: Ensure stable antibody production through proper subcloning techniques

The methodology used for other research antibodies, such as targeting the immunogen with spleen cells from immunized mice fused with myeloma cell lines, has proven effective in developing stable antibody-producing hybridomas .

What immunohistochemical protocols are recommended for SPCC622.15c detection in fixed yeast samples?

Based on protocols for other antibodies, the following methodology is recommended:

• Fixation optimization: Test both formaldehyde (4%) and methanol fixation methods

• Antigen retrieval: Implement heat-induced epitope retrieval using sodium citrate buffer (pH 6.0)

• Blocking parameters: Use 5% BSA or 10% normal serum with 0.1% Triton X-100

• Antibody dilution range: Test serial dilutions (1/50-1/500) to determine optimal signal-to-noise ratio

• Detection system: Utilize appropriate secondary antibodies with fluorescent or enzymatic labels

• Controls: Include both wild-type and SPCC622.15c deletion strains

For paraffin-embedded samples, heat treatment in sodium citrate buffer (pH 6.0) is particularly important for antigen retrieval, similar to protocols used for A6.4.12 clone antibodies .

How should researchers optimize flow cytometry protocols for SPCC622.15c detection?

For flow cytometry applications:

• Sample preparation: Optimize cell wall digestion with zymolyase or lysing enzymes

• Fixation protocol: Test paraformaldehyde (2-4%) and methanol fixation

• Permeabilization conditions: Evaluate Triton X-100 (0.1-0.5%) and saponin (0.1-0.3%)

• Antibody concentration: Start with 10μl of antibody per 1×10^6 cells in 100μl volume (similar to CD62P antibody protocols)

• Incubation parameters: Test both temperature (4°C vs. room temperature) and duration (30-60 minutes)

• Washing steps: Implement multiple PBS washes to reduce background

The working dilution ranges of 1/50 to 1/100 that have proven effective for other research antibodies in flow cytometry applications should serve as a starting point .

What are the critical considerations for using SPCC622.15c antibodies in co-immunoprecipitation experiments?

Key considerations include:

• Lysis buffer optimization: Test multiple buffers to maintain protein-protein interactions

• Pre-clearing protocol: Use appropriate pre-clearing steps to reduce non-specific binding

• Antibody-to-protein ratio: Typically 2-5μg antibody per 500μg protein lysate

• Incubation conditions: Overnight incubation at 4°C with gentle rotation

• Bead selection: Compare protein A/G, magnetic, and agarose beads for optimal capture

• Elution strategies: Evaluate different elution methods to maximize specificity

• Crosslinking considerations: Test DSS or BS3 crosslinking if interactions are transient

Affinity purification techniques similar to those used for PARP-1 and CD62P antibodies would be applicable, using Protein A affinity chromatography for purification .

How can researchers effectively use SPCC622.15c antibodies to study protein-glucan interactions during cell wall synthesis?

For studying protein-glucan interactions:

• In situ proximity ligation assays: Detect protein-glucan interactions with nanometer resolution

• Co-localization studies: Implement dual-labeling with glucan-binding dyes (e.g., aniline blue)

• Pull-down assays: Use immobilized glucan polymers to isolate interacting proteins

• FRET analysis: Assess protein-glucan proximity using fluorescently-labeled antibodies and glucan dyes

• Time-lapse imaging: Monitor dynamic changes during cell cycle or stress responses

This approach is particularly relevant given that SPCC622.15c likely relates to proteins involved in glucan synthesis and cell wall remodeling processes, as indicated by research on S. pombe cell wall organization .

What methodological approaches best resolve contradictory findings when using different SPCC622.15c antibody clones?

To resolve contradictory findings:

• Epitope mapping comparison: Determine if antibodies recognize different epitopes

• Cross-validation using orthogonal methods: Confirm results with non-antibody methods (e.g., mass spectrometry)

• Side-by-side protocol optimization: Test identical conditions with both antibodies

• Knockout/knockdown validation: Use genetic models to confirm specificity of each antibody

• Independent laboratory verification: Have findings reproduced in different laboratories

• Analytical validation: Implement more rigorous statistical analysis of results

This approach parallels observations with PD-L1 antibodies where different clones (SP142 vs. 22C3) showed significant differences in staining patterns and sensitivity, with 22C3 consistently showing higher detection rates and stronger staining compared to SP142 (66.7% vs. 39.6% for ≥5% expression and 45.8% vs. 22.9% for ≥50% expression) .

How can computational modeling enhance epitope prediction for generating highly specific SPCC622.15c antibodies?

Computational approaches include:

• Structural biology integration: Use protein structure predictions to identify accessible epitopes

• Machine learning algorithms: Implement AI-based epitope prediction tools

• Molecular dynamics simulations: Assess epitope flexibility and accessibility

• Cross-species conservation analysis: Identify unique vs. conserved regions

• Post-translational modification mapping: Account for modifications affecting epitope recognition

• In silico affinity maturation: Model antibody-antigen interactions to improve binding

This computational approach would be particularly valuable given the complex nature of fungal cell wall proteins and their interactions with polysaccharide structures like β-1,6-glucan polymers mentioned in the research .

What are the most common causes of non-specific binding when using antibodies against S. pombe proteins like SPCC622.15c?

Common causes and solutions include:

• Cell wall components interference: Implement more stringent washing with detergents

• High mannose glycosylation: Pre-absorb antibodies or use deglycosylation enzymes

• Cross-reactivity with related proteins: Validate against knockout strains

• Fc receptor binding: Use appropriate blocking reagents and Fab fragments

• Storage buffer incompatibilities: Test different formulations (avoid repeated freeze-thaw cycles)

• Fixation artifacts: Optimize fixation protocols for yeast cell samples

For long-term storage stability, avoid repeated freezing and thawing as this may denature the antibody, and frost-free freezers are not recommended - guidelines that apply to all research antibodies .

How should researchers interpret variations in SPCC622.15c detection across different strain backgrounds?

For interpreting strain-dependent variations:

• Expression level quantification: Use RT-qPCR to correlate protein detection with mRNA levels

• Post-translational modification analysis: Assess differential modification patterns

• Protein localization studies: Determine if subcellular distribution varies between strains

• Cell wall architecture differences: Evaluate accessibility of epitopes in different strain backgrounds

• Genetic background effects: Analyze potential modifier genes affecting target expression

• Experimental standardization: Implement rigorous controls for each strain background

This approach is supported by observations that different cellular contexts can significantly affect antibody detection sensitivity, as seen with PD-L1 expression differences between squamous cell carcinoma and non-squamous cell carcinoma tissues .

What quality control metrics should be implemented when using SPCC622.15c antibodies across different experimental batches?

Essential quality control measures include:

• Lot-to-lot validation: Test each new antibody lot against standard samples

• Positive control inclusion: Use recombinant SPCC622.15c or overexpression strains

• Titration curves: Establish optimal concentration for each application and lot

• Signal-to-noise ratio assessment: Quantify specific vs. background signal

• Inter-assay calibration: Include standard samples across experiments

• Storage stability monitoring: Test activity after various storage durations

For quantitative applications, establishing standard curves with purified protein at specified concentrations (similar to the 1.0 mg/ml concentration specified for other research antibodies) provides critical reference points .

How can SPCC622.15c antibodies be effectively employed in super-resolution microscopy studies?

For super-resolution applications:

• Fluorophore selection: Choose bright, photostable fluorophores compatible with STORM or PALM

• Sample preparation optimization: Develop S. pombe-specific protocols for optimal resolution

• Labeling density calibration: Determine optimal primary and secondary antibody concentrations

• Drift correction strategies: Implement fiducial markers for long acquisition times

• Multi-color imaging protocols: Establish spectral separation for co-localization studies

• Quantitative analysis pipelines: Develop algorithms for nanoscale distribution analysis

These approaches would allow visualization of SPCC622.15c distribution in relation to cell wall structures with nanometer precision, providing insights into protein localization patterns during different cellular processes.

What methodological adaptations are necessary for using SPCC622.15c antibodies in chromatin immunoprecipitation (ChIP) experiments?

For ChIP applications with S. pombe:

• Crosslinking optimization: Test formaldehyde concentrations (1-3%) and incubation times

• Cell wall digestion: Implement enzymatic pre-treatment for improved nuclear access

• Sonication parameters: Optimize chromatin fragmentation specific to S. pombe

• Antibody specificity validation: Perform ChIP-qPCR with known targets and non-targets

• Input normalization strategies: Develop S. pombe-specific normalization approaches

• Protein-DNA complex elution: Test different elution buffers for optimal recovery

This methodology would be particularly relevant if SPCC622.15c has any nuclear functions or interactions with genomic DNA, which would need to be established experimentally.

How can mass spectrometry be integrated with immunoprecipitation using SPCC622.15c antibodies to identify novel interacting partners?

For IP-MS integration:

• On-bead digestion protocols: Optimize trypsin digestion directly on immunoprecipitated complexes

• Crosslinking MS approaches: Implement DSS or formaldehyde crosslinking for transient interactions

• SILAC labeling integration: Use isotope labeling for quantitative interaction analysis

• Control strategies: Develop appropriate negative controls for background subtraction

• Bioinformatic analysis pipelines: Implement specialized algorithms for interaction network mapping

• Validation methodology: Establish criteria for confirming novel interactions

This approach would be valuable for identifying protein complexes involved in glucan synthesis and cell wall organization in which SPCC622.15c participates, potentially revealing new components of these cellular processes .